Swiss biopharma company BioVersys (today announced a research and exclusive license option agreement with the Japanese ...

Australian neurodegenerative diseases specialist Neurizon Therapeutics has agreed an exclusive global license agreement with ...

A federal judge has blocked the US Department of Health and Human Services from moving forward with a major workforce ...

Under the terms of the deal, HanchorBio will receive an upfront payment of $10 million, with additional payments tied to ...

Alnylam Pharmaceuticals (Nasdaq: ALNY) has won European Commission approval for Amvuttra (vutrisiran) to treat transthyretin ...

US pharma giant Merck & Co today revealed that the US Food and Drug Administration (FDA) has accepted and granted priority ...

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...

Artificial Intelligence (AI) is reshaping pharmacovigilance, promising faster detection of safety signals hidden within ...

California biotech Unnatural Products (UNP) announced a strategic multi-target research collaboration with Dutch immunology ...

US biotech IGM Biosciences yesterday revealed it has entered into a definitive merger agreement to be acquired by Concentra ...

Swiss biosimilars and generics major Sandoz has announced the start of construction for a new, state-of-the-art biosimilars ...

Hungarian drugmaker Gedeon Richter has announced that the European Commission has granted marketing authorization for the biosimilar denosumab products Junod and Yaxwer.